Brown Technology Innovations is thrilled to have Andrew Bond join our team as Senior Director of Business Development. He will support life science researchers and inventors as they engage with our office.

The Brown Biomedical Innovations to Impact (BBII) is an accelerator fund that supports biomedical technologies with high impact potential to become attractive to industry partners and investors.

Christina Bailey-Hytholt has been recognized in Forbes 30 under 30 in science.

RIBio is hosting RI Innovator Series: Zen and the Art of Starting Up a Start-up January 2022.

Brown Technology Innovations will attend the annual JPM Healthcare Conference, which will take place January in San Francisco, CA. Please contact us (tech-innovations@Brown.edu) with news or connections related to the conference.

The Brown Biomedical Innovations to Impact (BBII) is an accelerator fund that supports biomedical technologies with high impact potential to become attractive to industry partners and investors.

Brown licensee, Theromics, Inc. was recently awarded a Small Business Technology Transfer Grant and a patent (US11076916).

The Montreal start-up, Deeplite, licensed Brown technology developed by Sherief Reda (Engineering) with the goal of making computing faster and more accessible.

Nitin Padture Ph.D. (Engineering) and his team recently published data on use of a molecular glue that significantly enhances durability of perovskite solar panels.

Last month, Brown startup, Bolden, was awarded a Small Business Technology Transfer (SBTT) grant of $500,000 from the National Institute on Aging for their approach to enhance neurogenesis. Bolden Therapeutics is a biotechnology company that develops therapeutics to promote neurogenesis in patients with diseases that affect cognition, such as Alzheimer’s.

Keeping apace with prior months, three new patents were awarded to Brown for research from the labs of Michael Black, Computer Science, Sherief Reda, Engineering, and Ben Kimia, Engineering.

The first-ever Rhode Island Startup Week happens this month at RI Hub, a network of innovators, investors, students, citizens and those interested in building our economy through new ideas. Rhode Island Startup Week, October 18-22, is five days of events that showcase RI’s startup community, where local entrepreneurs can connect.

CIC Providence will host Climate Risk, Insurance & Innovation on October 6th.

Last month, Brown was awarded three patents: (1) for Jacob Rosenstein’s work on chemical computation methods (US 11,093,865); (2) Samir Gadre’s innovation to facilitate human training of robots (US 11,090,813); and (3) Peter Weber’s spectroscopy enhancing chemical vapor detection (US 11,099,129).

George Karniadakis (Applied Math and Engineering) and his team recently received press coverage for DeepONet, a method they developed that uses neural networks to solve families of Partial Differential Equations (PDE).

Oxford Nanopore announced a London IPO after reaching a $3.3B valuation.

Brown Technology Innovations’ 2021 Annual Report highlights our highest recorded number of invention disclosures and 87% growth in industry sponsored research agreements, driven by Brown faculty inventors.

Brown Biomedical Innovations to Impact (BBII) will fund four projects to accelerate their commercialization.

Congratulations to Brown faculty for the most productive year for inventions to date with 90 invention disclosures received to date, surpassing the previous high of 76 in 2017!

Therapyx has licensed from Brown a proprietary protein micronization and encapsulation process developed by Edith Matthiowitz (Engineering).

Brown was awarded a new patent last month (US 11,034,019) for a method enabling a robot to learn a mapping between English language commands and Linear Temporal Logic expressions, developed in the lab of Stefanie Tellex (Computer Science).The patent, which relates to robotics, would allow for non-experts to engage with particular robots without programming knowledge.

Last month, the Brown-Lifespan Center for Digital Health hosted it’s 2021 virtual conference, “Leveraging Digital Health for the Post-Pandemic World.”

RIHUB is hosting RI Startup Weekend online this year on November 20-21.

Brown is one of fifteen leading universities who will aggregate their engineering and physical science patents into broad bundles of technologies for commercialization as part of the University Technology Licensing Program (UTLP).

Nitin Padture’s research team has developed a molecular glue that increases the efficiency of perovskite solar cells in converting sunlight into electricity. This work, published in Science, was included in a recent patent application guided by Brown Technology Innovations.

Oxford Nanopore raised $217M in a recent funding round to further develop its genetic sequencing technology. The UK-based company offers sequencing technology capable of analyzing a single DNA or RNA molecule at a time while providing data in real time.

AUTM offers a guide for matching technologies with an industry partner in their Marketing to Industry Toolkit.

Our team describes ways that Brown researchers can explore commercial pathways for life sciences discoveries, including licensing, sponsored research agreements, and startups.

Deeplite, a start-up based in Montreal, closed a $6-million seed fundraising round to “bring AI to Everyday Life”. Power and processor capacity are two big limitations to AI and deep learning. Deeplite’s automated software engine enables AI computing on any device.

Brown was awarded a patent for research by Gang Xiao (Physics) on ultrasensitive magnetic tunneling junction (MTJ) sensors (US 10,983,182).

The National Science Foundation bestowed a CAREER Award to Kareen Coulombe, Assistant Professor of Engineering, Molecular Pharmacology, Physiology and Biotechnology. The award supports work included in a recent patent application (guided by the Brown Technology Innovations office).

With two gifts to the university totaling $30 million, Brown will establish a new Center for Alzheimer’s Disease Research.

The 2021 Digital Health Virtual Conference will be held on June 22.

RIHub facilitates connections between entrepreneurs and industry leaders through its many programs, including mentoring, networking, and community events.

The University of Vermont is offering an intensive Biomedical Entrepreneurship summer course in June.

A new patent has been issued this month for work in the lab of Dr. George Karniadakis (US 10,963,540).

BTI kicks off a monthly initiative to share resources focused on educating and encouraging faculty interested in patents, startups and licensing.

Brown is partnering with BridgeBio to advance new treatments for neurological diseases with genetic origins.

The annual AUTM meeting supports engagement between industry partners and university tech transfer offices.

A key strategy to achieve financial sustainability is to achieve diversity in revenue streams.

At a conference, the conversation in the hallways is often where the insights and connections happen.

Looking back a year—everyone is doing it—we see Brown inventors who pivoted to find ways to address the pandemic.

Last month, Brown was awarded three patents. Christoph Rose-Petruck and Brian Sheldon led the research behind an in-situ x-ray scatter imaging of battery electrodes (US 10,833,374).

The J.P. Morgan Health Care Conference presents a unique opportunity to connect with investors and companies in the biomedical field gathered in one place.

Tech Innovations hosted Elm Street Ventures (ESV) in January to showcase five life science research projects with potential for commercial applications.

Tech Innovations has accelerated its work to connect Brown inventors with entrepreneurs who can guide their approach to commercial applications of their research.

Dr. Ashish Jha, Dean of the Brown University School of Public Health, has announced that Dr. Megan Ranney has agreed to serve as the School’s Associate Dean for Strategy and Innovation.

Brown Technology Innovations is thrilled to have Melissa Simon join our team as Business Development Director。

A startup based on research by Justin Fallon and Ashley Webb, Bolden Therapeutics, recently won the “Golden Ticket” award from BioGen.